Display options
Cite
Schneider M, Efferth T, Abdel-Aziz H. Anti-inflammatory Effects of Herbal Preparations STW5 and STW5-II in Cytokine-Challenged Normal Human Colon Cells. Front Pharmacol. 2016;7:393doi: 10.3389/fphar.2016.00393.
Schneider, M., Efferth, T., & Abdel-Aziz, H. (2016). Anti-inflammatory Effects of Herbal Preparations STW5 and STW5-II in Cytokine-Challenged Normal Human Colon Cells. Frontiers in pharmacology, 7393. https://doi.org/10.3389/fphar.2016.00393
Schneider, Mathias, et al. "Anti-inflammatory Effects of Herbal Preparations STW5 and STW5-II in Cytokine-Challenged Normal Human Colon Cells." Frontiers in pharmacology vol. 7 (2016): 393. doi: https://doi.org/10.3389/fphar.2016.00393
Schneider M, Efferth T, Abdel-Aziz H. Anti-inflammatory Effects of Herbal Preparations STW5 and STW5-II in Cytokine-Challenged Normal Human Colon Cells. Front Pharmacol. 2016 Oct 26;7:393. doi: 10.3389/fphar.2016.00393. eCollection 2016. PMID: 27833553; PMCID: PMC5080345.
Copy Download .nbib Format: NLM
Share it on

Front Pharmacol. 2016 Oct 26;7:393. doi: 10.3389/fphar.2016.00393. eCollection 2016.

Anti-inflammatory Effects of Herbal Preparations STW5 and STW5-II in Cytokine-Challenged Normal Human Colon Cells.

Frontiers in pharmacology

Mathias Schneider, Thomas Efferth, Heba Abdel-Aziz

Affiliations

  1. Department of Pharmaceutical Biology, Johannes Gutenberg University, Mainz Germany.
  2. Department of Pharmaceutical Biology, Johannes Gutenberg University, MainzGermany; Medical and Clinical Affairs Phytomedicines, Steigerwald Arzneimittelwerk GmbH, Bayer Consumer Health, DarmstadtGermany.

PMID: 27833553 PMCID: PMC5080345 DOI: 10.3389/fphar.2016.00393

Abstract

Inflammatory bowel diseases (IBD) are chronic relapsing intestinal disorders characterized by up-regulation of pro-inflammatory cytokines followed by invasion of immune cells to the intestinal lamina propria. Standard therapies consist of anti-inflammatory or immunosuppressive drugs. Since clinical efficiency is not satisfactory and the established drugs have massive side effects, new strategies to treat IBD are required. Herein, we investigate the protective effect of the fixed combination herbal preparations STW5 and STW5-II and the contribution of the corresponding single components in an

Keywords: Inflammatory bowel disease; Phytotherapy; Proteomics

References

  1. Food Chem. 2013 Aug 15;139(1-4):339-46 - PubMed
  2. Mol Med. 2015 Nov 24;:null - PubMed
  3. Inflamm Bowel Dis. 2013 Feb;19(2):265-74 - PubMed
  4. J Pediatr. 2003 Oct;143(4):525-31 - PubMed
  5. Clin Nutr. 2004 Aug;23(4):579-85 - PubMed
  6. Matrix Biol. 2002 Apr;21(3):251-62 - PubMed
  7. Mutat Res. 2007 Sep 1;622(1-2):70-83 - PubMed
  8. J Dig Dis. 2011 Oct;12(5):327-32 - PubMed
  9. Molecules. 2014 Dec 16;19(12):21127-53 - PubMed
  10. Phytomedicine. 2006;13 Suppl 5:12-9 - PubMed
  11. Phytomedicine. 2015 Nov 15;22(12):1063-70 - PubMed
  12. Eur J Radiol. 2000 Sep;35(3):154-67 - PubMed
  13. Inflamm Bowel Dis. 2012 Aug;18(8):1456-69 - PubMed
  14. Biochem Pharmacol. 2011 Feb 1;81(3):412-24 - PubMed
  15. Curr Opin Genet Dev. 2002 Feb;12(1):14-21 - PubMed
  16. Wien Med Wochenschr. 2004 Nov;154(21-22):528-34 - PubMed
  17. J Nutr. 2015 Jul;145(7):1604-13 - PubMed
  18. Food Chem Toxicol. 2009 Jun;47(6):1221-30 - PubMed
  19. Am J Physiol Lung Cell Mol Physiol. 2015 Apr 1;308(7):L650-7 - PubMed
  20. J Biol Chem. 1999 Apr 30;274(18):12229-35 - PubMed
  21. Lab Invest. 2008 Jun;88(6):652-63 - PubMed
  22. Am J Gastroenterol. 2008 Jan;103(1):162-9 - PubMed
  23. Gastroenterology. 2001 Jan;120(1):49-59 - PubMed
  24. Clin Exp Immunol. 2009 Oct;158(1):45-54 - PubMed
  25. N Engl J Med. 2011 Nov 3;365(18):1713-25 - PubMed
  26. Mol Med. 2012 Dec 20;18:1412-9 - PubMed
  27. J Pharmacol Sci. 2010;113(2):134-42 - PubMed
  28. Phytomedicine. 2013 Jun 15;20(8-9):691-8 - PubMed
  29. Gut. 2014 Mar;63(3):442-50 - PubMed
  30. Planta Med. 2004 Feb;70(2):93-103 - PubMed
  31. J Crohns Colitis. 2015 Jan;9(1):56-65 - PubMed
  32. Mol Immunol. 2015 Mar;64(1):183-9 - PubMed
  33. Int J Colorectal Dis. 2012 Nov;27(11):1445-53 - PubMed
  34. Mediators Inflamm. 2014;2014:818251 - PubMed
  35. Mediators Inflamm. 1997;6(2):95-103 - PubMed
  36. J Biol Chem. 2003 Jul 25;278(30):27620-9 - PubMed
  37. Phytomedicine. 2009 Mar;16(2-3):161-71 - PubMed
  38. Science. 2002 May 31;296(5573):1634-5 - PubMed
  39. Expert Opin Drug Saf. 2015 Jun;14(6):987-97 - PubMed
  40. Naunyn Schmiedebergs Arch Pharmacol. 2012 Apr;385(4):411-21 - PubMed
  41. Nature. 2007 Jul 26;448(7152):427-34 - PubMed
  42. Gut. 2002 Sep;51(3):379-85 - PubMed
  43. J Cell Sci. 2004 Dec 1;117(Pt 25):5965-73 - PubMed
  44. Eur J Biochem. 2000 Sep;267(17):5421-6 - PubMed
  45. Clin Exp Immunol. 2011 Jun;164(3):396-406 - PubMed
  46. Cell Death Differ. 2003 Jan;10(1):45-65 - PubMed
  47. Nat Med. 1996 Sep;2(9):998-1004 - PubMed
  48. Gut. 1989 Sep;30(9):1236-40 - PubMed
  49. Clin Exp Immunol. 1994 Jun;96(3):432-6 - PubMed
  50. Clin Exp Immunol. 2016 Mar;183(3):358-68 - PubMed
  51. Rheumatology (Oxford). 2012 Nov;51(11):1966-72 - PubMed
  52. In Vitro Cell Dev Biol Anim. 1996 Jun;32(6):315-7 - PubMed
  53. Wien Med Wochenschr. 2007;157(13-14):301-7 - PubMed
  54. J Pathol. 2003 Jan;199(1):28-35 - PubMed
  55. Altern Med Rev. 2011 Jun;16(2):116-33 - PubMed
  56. Inflamm Res. 2012 Sep;61(9):977-85 - PubMed
  57. N Engl J Med. 2009 Nov 19;361(21):2066-78 - PubMed

Publication Types